Sign in

CIK 0000873303

  • Large accelerated filer

Sarepta Therapeutics, Inc.

Sign in to watch
Ticker
SRPT
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
930797222
Phone
+1 617-274-4000
Business address
215 FIRST STREET, SUITE 415, CAMBRIDGE, MA, 02142
Former names
Sarepta Therapeutics, Inc., AVI BIOPHARMA INC, ANTIVIRALS INC
  1. 4 Shares withheld for taxes Chief Tech Ops Officer gave up 340 shares (to pay taxes)
  2. 4 Shares withheld for taxes Chief Financial Officer gave up 1,370 shares (to pay taxes)
  3. 4 Grant or award Director acquired 1,523 shares (grant or award)
  4. 4 Shares withheld for taxes Head of R&D, CSO gave up 1,134 shares (to pay taxes)
  5. 4 Grant or award Director acquired 1,523 shares (grant or award)
  6. 4 Shares withheld for taxes SVP, General Counsel gave up 1,325 shares (to pay taxes)
  7. 4 Grant or award Director acquired 1,523 shares (grant or award)
  8. 4 Grant or award Director acquired 1,523 shares (grant or award)
  9. 4 Grant or award Director acquired 1,523 shares (grant or award)
  10. 4 Grant or award Director acquired 1,523 shares (grant or award)
  11. 4 Shares withheld for taxes Chief Tech Ops Officer gave up 252 shares (to pay taxes)
  12. 4 Shares withheld for taxes SVP, General Counsel gave up 196 shares (to pay taxes)
  13. 4 Shares withheld for taxes Chief Financial Officer gave up 378 shares (to pay taxes)
  14. 4 Shares withheld for taxes Head of R&D, CSO gave up 522 shares (to pay taxes)
  15. 4 Derivatives Options or other derivatives
  16. 3 Insider Initial Statement of Ownership
  17. 4 Exercise or conversion Director acquired 20,000 shares (option exercise)
  18. 4 Shares withheld for taxes Head of R&D, CSO gave up 4,211 shares (to pay taxes)
  19. 4 Open-market sale Director sold 858 shares at $109.92 ($94,311)
  20. 4 Open-market buy Director bought 57,100 shares at an average $104.43 ($5,963,124)

Page 8 of 34 · 672 filings